Chimera Investment (NYSE: CIM) insider transactions
In the twelve months to 10 November 2026, executives and directors of Chimera Investment reported no open-market sales and no open-market purchases, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 11 June 2026 | Creagh Gerard | Director | Grant or award | +11,263 | — | 188,015 | Form 4 |
| 11 June 2026 | Reilly Brian Patrick | Director | Grant or award | +11,263 | — | 106,133 | Form 4 |
| 11 June 2026 | Walsh Cynthia B | Director | Grant or award | +11,263 | — | 26,765 | Form 4 |
| 11 June 2026 | Chavers Kevin Gerald | Director | Grant or award | +11,263 | — | 50,506 | Form 4 |
| 11 June 2026 | Still Debra | Director | Grant or award | +11,263 | — | 60,706 | Form 4 |
| 11 June 2026 | Mills Susan | Director | Grant or award | +11,263 | — | 37,757 | Form 4 |
| 17 February 2026 | Kardis Phillip John II | President and CEO | Shares withheld for tax | −127,168 | $13.70 | 579,085 | Form 4 |
| 17 February 2026 | Viswanathan Subramaniam | Chief Financial Officer | Shares withheld for tax | −51,800 | $13.70 | 200,507 | Form 4 |
| 17 February 2026 | Macdowell Jack Lee Jr | Chief Investment Officer | Shares withheld for tax | −12,200 | $13.70 | 302,421 | Form 4 |
| 17 February 2026 | Sung Miyun | Chief Legal Officer & Secy. | Shares withheld for tax | −8,165 | $13.70 | 60,836 | Form 4 |
| 20 January 2026 | Kardis Phillip John II | President and CEO | Grant or award | +194,774 | — | 695,495 | Form 4 |
| 20 January 2026 | Sung Miyun | Chief Legal Officer & Secy. | Grant or award | +31,164 | — | 67,958 | Form 4 |
| 20 January 2026 | Viswanathan Subramaniam | Chief Financial Officer | Grant or award | +54,537 | — | 247,826 | Form 4 |
| 20 January 2026 | Macdowell Jack Lee Jr | Chief Investment Officer | Grant or award | +85,701 | — | 312,791 | Form 4 |
| 18 December 2025 | Viswanathan Subramaniam | Chief Financial Officer | Grant or award | +47,251 | — | 193,289 | Form 4 |
| 18 December 2025 | Kardis Phillip John II | President and CEO | Grant or award | +101,772 | — | 500,721 | Form 4 |
| 1 December 2025 | Kardis Phillip John II | President and CEO | Shares withheld for tax | −102,926 | $12.79 | 394,169 | Form 4 |
| 1 December 2025 | Viswanathan Subramaniam | Chief Financial Officer | Shares withheld for tax | −31,675 | $12.79 | 145,931 | Form 4 |
| 1 December 2025 | Sung Miyun | Chief Legal Officer & Secy. | Shares withheld for tax | −2,586 | $12.79 | 36,794 | Form 4 |
| 10 June 2025 | Creagh Gerard | Director | Grant or award | +9,685 | — | 159,065 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Chimera Investment page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.